This inventor holds 6 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Sichuan Jiuzhang Biological Science and Technology Co., Ltd., Sichuan Deep & Fast Oil Drilling Tools Co., Ltd. Active years: 2017-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 18 
2 out of 2 Years Active: 2017-2025
Title: Innovations of Liang Zhang in Ocular Inflammation Treatment
Introduction
Liang Zhang is a notable inventor based in Sichuan, China, recognized for his contributions to the field of medicinal chemistry. He holds a total of six patents, focusing primarily on the use of chlorogenic acid in the treatment of ocular inflammation. His innovative approaches have the potential to significantly impact the medical community.
Latest Patents
Liang Zhang's latest patents include the use of chlorogenic acid in the preparation of drugs aimed at preventing and treating ocular inflammation. This patent highlights the ability of chlorogenic acid to alleviate symptoms associated with uveitis and scleritis, showcasing its effectiveness in treating ocular inflammation. Another significant patent involves a preparation containing a chlorogenic acid crystal form, characterized by its orthorhombic crystal system. The specific parameters of this crystal form include a space group of P222 and cell dimensions that enhance its bioavailability. This preparation can be utilized in medicines for treating various conditions, including tumors, psoriasis, and cardiovascular diseases.
Career Highlights
Throughout his career, Liang Zhang has worked with prominent companies such as Sichuan Jiuzhang Biological Science and Technology Co., Ltd. and Sichuan Deep & Fast Oil Drilling Tools Co., Ltd. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Liang Zhang has collaborated with notable colleagues, including Jie Zhang and Wang Huang. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of innovative solutions.
Conclusion
Liang Zhang's work in the field of ocular inflammation treatment through the use of chlorogenic acid represents a significant advancement in medicinal chemistry. His patents and collaborations reflect a commitment to innovation that could lead to improved health outcomes for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile